Synthon's mission is to make healthcare more affordable and to improve access to important medicines through the provision of high-quality small-molecule generics and hybrids to patients all around the world. Currently, our products are approved by regulatory agencies in around 100 countries and marketed through strategic partnerships and - in dedicated areas - through direct sales.
read more about our business